The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, T. J.
Right arrow Articles by Marquardt, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, T. J.
Right arrow Articles by Marquardt, H.

The Journal of Immunology, Vol 139, Issue 9 2977-2983, Copyright © 1987 by American Association of Immunologists

ARTICLES

Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells

TJ Brown, MN Lioubin and H Marquardt
Department of Biochemistry, ONCOGEN, Seattle, WA 98121.

Supernatants from activated human T lymphocytes were highly growth inhibitory for A375 human melanoma cells. Three growth inhibiting polypeptides, transforming growth factor beta 1 (TGF-beta 1), interferon-gamma (IFN-gamma), and oncostatin M, were isolated from the acid-soluble fraction of serum-free T cell-conditioned medium and purified by gel permeation chromatography and reverse-phase high performance liquid chromatography in volatile solvents at acid pH. The purification was monitored in a growth inhibition assay. The release of TGF-beta 1 biologic activity by and the purification of IFN-gamma from the medium of activated human peripheral blood T lymphocytes have been reported. We now describe the isolation of oncostatin M from the conditioned medium of activated human T cells. The concentration of oncostatin M required for half-maximal inhibition of A375 melanoma cells was approximately 4 pM when assayed in the presence of 10% fetal bovine serum. The purified oncostatin M had an apparent m.w. 28,000 and an amino-terminal sequence that was identical with the sequence of oncostatin M isolated from supernatants of macrophage-like cells. Suboptimal concentrations of TGF-beta 1 in combination with suboptimal concentrations of IFN-gamma or oncostatin M resulted in synergistic antiproliferative responses for A375 cells (1.9 and 3.1 times the expected additive responses, respectively). Combinations of oncostatin M and IFN-gamma added simultaneously to A375 cells caused an additive growth inhibitory response. These results demonstrate that oncostatin M is a novel lymphokine, and its interaction with other cytostatic polypeptide growth inhibitors may play a role in the immune regulation of tumor cell growth.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. Hintzen, C. Evers, B. E. Lippok, R. Volkmer, P. C. Heinrich, S. Radtke, and H. M. Hermanns
Box 2 Region of the Oncostatin M Receptor Determines Specificity for Recruitment of Janus Kinases and STAT5 Activation
J. Biol. Chem., July 11, 2008; 283(28): 19465 - 19477.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. P. Kastl, W. S. Speidl, C. Kaun, K. M. Katsaros, G. Rega, T. Afonyushkin, V. N. Bochkov, P. Valent, A. Assadian, G. W. Hagmueller, et al.
In Human Macrophages the Complement Component C5a Induces the Expression of Oncostatin M via AP-1 Activation
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Diveu, E. Venereau, J. Froger, E. Ravon, L. Grimaud, F. Rousseau, S. Chevalier, and H. Gascan
Molecular and Functional Characterization of a Soluble Form of Oncostatin M/Interleukin-31 Shared Receptor
J. Biol. Chem., December 1, 2006; 281(48): 36673 - 36682.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Underhill-Day and J. K. Heath
Oncostatin M (OSM) Cytostasis of Breast Tumor Cells: Characterization of an OSM Receptor {beta}-Specific Kernel.
Cancer Res., November 15, 2006; 66(22): 10891 - 10901.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
P. J. Lafontant, A. R. Burns, E. Donnachie, S. B. Haudek, C. W. Smith, and M. L. Entman
Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts
Am J Physiol Cell Physiol, July 1, 2006; 291(1): C18 - C26.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Stross, S. Radtke, T. Clahsen, C. Gerlach, R. Volkmer-Engert, F. Schaper, P. C. Heinrich, and H. M. Hermanns
Oncostatin M Receptor-mediated Signal Transduction Is Negatively Regulated by SOCS3 through a Receptor Tyrosine-independent Mechanism
J. Biol. Chem., March 31, 2006; 281(13): 8458 - 8468.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
W. G. Douglas, E. Tracy, D. Tan, J. Yu, W. L. Hicks Jr., N. R. Rigual, T. R. Loree, Y. Wang, and H. Baumann
Development of Head and Neck Squamous Cell Carcinoma Is Associated With Altered Cytokine Responsiveness
Mol. Cancer Res., October 1, 2004; 2(10): 585 - 593.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Tanaka, Y. Hirabayashi, T. Sekiguchi, T. Inoue, M. Katsuki, and A. Miyajima
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
Blood, November 1, 2003; 102(9): 3154 - 3162.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
F Ensoli, V Fiorelli, A Lugaresi, D Farina, M DeCristofaro, B Collacchi, D S. Muratori, E Scala, M Di Gioacchino, R Paganelli, et al.
Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors {alpha} and {beta}, and interferon {gamma}
Multiple Sclerosis, August 1, 2002; 8(4): 284 - 288.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
P. Repovic and E. N. Benveniste
Prostaglandin E2 Is a Novel Inducer of Oncostatin-M Expression in Macrophages and Microglia
J. Neurosci., July 1, 2002; 22(13): 5334 - 5343.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. S. K. de Hooge, F. A. J. van de Loo, M. B. Bennink, D. S. de Jong, O. J. Arntz, E. Lubberts, C. D. Richards, and W. B. van den Berg
Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-{kappa}B Ligand
Am. J. Pathol., May 1, 2002; 160(5): 1733 - 1743.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
Y. Ohata, T. Harada, A. Fujii, S. Yoshida, T. Iwabe, and N. Terakawa
Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M
Mol. Hum. Reprod., July 1, 2001; 7(7): 665 - 670.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
W Hui, A D Rowan, and T Cawston
Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1{alpha}
Ann Rheum Dis, March 1, 2001; 60(3): 254 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
C. Bernard, R. Merval, M. Lebret, P. Delerive, I. Dusanter-Fourt, S. Lehoux, C. Creminon, B. Staels, J. Maclouf, and A. Tedgui
Oncostatin M Induces Interleukin-6 and Cyclooxygenase-2 Expression in Human Vascular Smooth Muscle Cells : Synergy With Interleukin-1{beta}
Circ. Res., December 3, 1999; 85(12): 1124 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
J. Liu, C. Li, T. E. Ahlborn, M. J. Spence, L. Meng, and L. M. Boxer
The Expression of p53 Tumor Suppressor Gene in Breast Cancer Cells Is Down-Regulated by Cytokine Oncostatin M
Cell Growth Differ., October 1, 1999; 10(10): 677 - 683.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
F. Ensoli, V. Fiorelli, M. DeCristofaro, D. Santini Muratori, A. Novi, B. Vannelli, C. J. Thiele, G. Luzi, and F. Aiuti
Inflammatory Cytokines and HIV-1-Associated Neurodegeneration: Oncostatin-M Produced by Mononuclear Cells from HIV-1-Infected Individuals Induces Apoptosis of Primary Neurons
J. Immunol., May 15, 1999; 162(10): 6268 - 6277.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Grenier, M. Dehoux, A. Boutten, M. Arce-Vicioso, G. Durand, M.-A. Gougerot-Pocidalo, and S. Chollet-Martin
Oncostatin M Production and Regulation by Human Polymorphonuclear Neutrophils
Blood, February 15, 1999; 93(4): 1413 - 1421.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. M. Botelho, D. R. Edwards, and C. D. Richards
Oncostatin M Stimulates c-Fos to Bind a Transcriptionally Responsive AP-1 Element within the Tissue Inhibitor of Metalloproteinase-1 Promoter
J. Biol. Chem., February 27, 1998; 273(9): 5211 - 5218.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Liu, Y. L. Zhang, M. J. Spence, R. E. Vestal, P. M. Wallace, and D. S. Grass
Liver LDL Receptor mRNA Expression Is Decreased in Human ApoB/CETP Double Transgenic Mice and Is Regulated by Diet as Well as the Cytokine Oncostatin M
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2948 - 2954.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
H. Ihn, E. C. LeRoy, and M. Trojanowska
Oncostatin M Stimulates Transcription of the Human alpha 2(I) Collagen Gene via the Sp1/Sp3-binding Site
J. Biol. Chem., September 26, 1997; 272(39): 24666 - 24672.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Korzus, H. Nagase, R. Rydell, and J. Travis
The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1Gene Expression
J. Biol. Chem., January 10, 1997; 272(2): 1188 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
E. Wijelath, B Carlsen, T Cole, J Chen, S Kothari, and W. Hammond
Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology
J. Cell Sci., January 4, 1997; 110(7): 871 - 879.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman
Dual Oncostatin M (OSM) Receptors. CLONING AND CHARACTERIZATION OF AN ALTERNATIVE SIGNALING SUBUNIT CONFERRING OSM-SPECIFIC RECEPTOR ACTIVATION
J. Biol. Chem., December 20, 1996; 271(51): 32635 - 32643.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
T Kishimoto, S Akira, and T Taga
Interleukin-6 and its receptor: a paradigm for cytokines
Science, October 23, 1992; 258(5082): 593 - 597.
[Abstract] [PDF]

Home page
 ScienceHome page
B. Nair, A. DeVico, S Nakamura, T. Copeland, Y Chen, A Patel, T O'Neil, S Oroszlan, R. Gallo, and M. Sarngadharan
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M
Science, March 13, 1992; 255(5050): 1430 - 1432.
[Abstract] [PDF]

Home page
 ScienceHome page
S. Miles, O Martinez-Maza, A Rezai, L Magpantay, T Kishimoto, S Nakamura, S. Radka, and P. Linsley
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells
Science, March 13, 1992; 255(5050): 1432 - 1434.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
J. Cichy and E. Pure
Oncostatin M and Transforming Growth Factor-beta 1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells
J. Biol. Chem., June 9, 2000; 275(24): 18061 - 18069.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.